Abdallah AlMousa

High Efficacy of ombitasvir/paritaprevir/ritonavir plus dasabuvir in hepatitis C genotypes 4 and 1–infected patients with severe chronic kidney disease

F. Sanai, A. Assiri, M. Aseeri, 2018, Liver international : official journal of the International Association for the Study of the Liver.

Real life efficacy of ledipasvir/sofosbuvir in hepatitis C genotype 4-infected patients with advanced liver fibrosis and decompensated cirrhosis.

F. Sanai, A. Assiri, A. Abdo, 2018, The Journal of infection.

High Efficacy of ombitasvir/paritaprevir/ritonavir plus dasabuvir in hepatitis C genotypes 4 and 1–infected patients with severe chronic kidney disease

F. Sanai, A. Assiri, M. Aseeri, 2018, Liver international : official journal of the International Association for the Study of the Liver.